• Hydroxycinnamic Acids Target COPII to Modulate cGAS-STING In

  2026-07-31

  This study reveals that hydroxycinnamic acids (HCAs) directly bind the Sec24 B-site of the COPII complex, inhibiting COPII-mediated STING trafficking and thereby attenuating inflammation via the cGAS-STING axis. These findings illuminate a precise molecular mechanism underlying the anti-inflammatory and metabolic benefits of HCA-rich traditional Chinese medicines, providing a foundation for novel therapeutic strategies in metabolic and autoinflammatory disorders.

• Optimizing Cell Assays with PDGF-BB, Murine Recombinant Prot

  2026-07-31

  This article addresses common laboratory challenges in cell viability and proliferation assays, highlighting how PDGF-BB, murine recombinant protein (SKU P1048) ensures data reliability and reproducibility. By integrating scenario-driven Q&A, evidence-backed parameters, and vendor selection guidance, it empowers researchers to implement robust protocols using this research-grade growth factor.

• Ferroelectric-Liquid Metal Hybrid Photoreceptors Restore Vis

  2026-07-30

  This study introduces a ferroelectric-liquid metal hybrid artificial photoreceptor that closely mimics human visual adaptation. The device demonstrates robust photoelectric performance and restores vision in rodent models of retinal degeneration, offering promise for advanced retinal prosthesis design.

• ESCO2 as a Pan-Cancer Biomarker: Insights from Expression an

  2026-07-30

  Huang et al. present the first comprehensive pan-cancer analysis of ESCO2, revealing its widespread oncogenic overexpression and prognostic significance across diverse tumor types. Their study integrates multi-omics database mining with in vitro functional validation, highlighting ESCO2’s central role in cell cycle regulation and its potential as a therapeutic target.

• Species-Specific Roles of SHH and FGF Signaling in Penile De

  2026-07-29

  This study identifies how differential expression of Shh, Fgf10, and Fgfr2 shapes distinct mechanisms of prepuce and urethral groove formation in mice versus guinea pigs. The findings refine our understanding of mammalian penile development and provide a more accurate model for investigating human congenital malformations.

• Immune Rejuvenation Mitigates Alzheimer’s Pathology in Mice

  2026-07-29

  Sun et al. demonstrate that transplantation of young bone marrow into aged Alzheimer’s disease (AD) model mice rejuvenates peripheral immune cells, restoring gene expression profiles and reducing AD-like neuropathology. This work highlights immune system rejuvenation as a promising therapeutic concept for AD and refines the understanding of immunosenescence in neurodegenerative disease progression.

• Lypressin Acetate: Strategic Leverage in Translational Resea

  2026-07-28

  This article explores the mechanistic, experimental, and translational value of lypressin acetate for researchers advancing vasopressin analogues, bridging endocrine and antiviral domains. It integrates peer-reviewed evidence, protocol parameters, and strategic guidance, positioning APExBIO’s Lypressin acetate as a gold-standard tool for precision and innovation.

• Pertussis Toxin: Optimizing Immune Modulation Workflows

  2026-07-28

  Pertussis toxin is a gold-standard AB5-type protein exotoxin for dissecting immune response pathways and signal transduction in translational immunology. This guide delivers actionable protocol enhancements, troubleshooting strategies, and experimental insights for maximizing data reliability in dendritic cell and T cell studies.

• Anti Reverse Cap Analog (ARCA): Enabling High-Fidelity Synth

  2026-07-27

  Explore how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, empowers next-generation synthetic mRNA applications with precision capping and translational efficiency. This article uniquely dissects ARCA's impact on cell fate engineering and mRNA therapeutics research.

• Anisomycin as a JNK Agonist: Practical Workflows and Trouble

  2026-07-27

  Anisomycin, a precision JNK agonist from APExBIO, enables robust apoptosis induction and cell signaling studies across cancer and neurobiology models. This article distills assay-ready workflows, experimental insights, and expert troubleshooting guidance drawn from recent advances and benchmarked protocols.

• Protease Inhibitor Cocktail: Precision in Lipid Droplet Assa

  2026-07-26

  Safeguard protein complexes and drive reproducible results in lipid droplet metabolism research with the Protease Inhibitor Cocktail (100X H₂O, EDTA Plus). This ready-to-use solution from APExBIO empowers reliable protein extraction and enables advanced studies into DFCP1-ATGL regulatory mechanisms.

• Anti Reverse Cap Analog (ARCA): Unlocking Reliable mRNA Tran

  2026-07-25

  Explore how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, optimizes mRNA capping for robust translation in cell reprogramming and synthetic biology. This article uniquely connects high-efficiency capping to breakthrough applications in stem cell differentiation, distinguishing ARCA's role beyond conventional workflows.

• PDHA1 Succinylation Drives Immune Escape in Cholangiocarcino

  2026-07-24

  This study reveals that succinylation of PDHA1 at lysine 83 in cholangiocarcinoma alters metabolic flux, leading to α-ketoglutaric acid accumulation and impaired macrophage antigen presentation. The findings underscore the therapeutic potential of targeting PDHA1 succinylation to enhance chemotherapy efficacy and modulate tumor-immune interactions.

• Dextran Sulfate Sodium Salt: Elevating DSS Colitis Models

  2026-07-24

  Dextran sulfate sodium salt (MW 35000-45000) powers robust, translational mouse models of inflammatory bowel disease by reliably inducing acute and chronic intestinal inflammation. This guide details advanced workflows, protocol enhancements, and troubleshooting insights to maximize experimental reproducibility and leverage cutting-edge mechanistic findings for ulcerative colitis research.

• Ellagic Acid as a Precision Probe for Senescence and CK2 Sig

  2026-07-23

  Explore how Ellagic acid, a selective CK2 inhibitor, is advancing cancer biology and senescence assay strategies. This article uniquely connects mechanistic insight with next-generation senolytic discovery, offering new perspectives beyond standard protocols.

16196 records 1/1080 page Next 12345 下5页 Last page